Global Natural Biomaterial Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Natural Biomaterial Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Healthcare
  • Upcoming Report
  • Mar 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Natural Biomaterial Market

Market Size in USD Billion

CAGR :  % Diagram

Bar chart comparing the Global Natural Biomaterial Market size in 2024 - 128.88 and 2032 - 205.10, highlighting the projected market growth. USD 128.88 Billion USD 205.10 Billion 2024 2032
Diagram Forecast Period
2025 –2032
Diagram Market Size (Base Year)
USD 128.88 Billion
Diagram Market Size (Forecast Year)
USD 205.10 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Natural Biomaterial Market Segmentation, By Type (Hyaluronic Acid, Collagen, Gelatin, Heparin, Fibrin, Cellulose, Chitosan, and Others), Application (Regenerative Medicine, Gene Therapy, Immunotherapy, Stem-Cell Therapy, Cardiovascular, Orthopaedic, Dental, Plastic Surgery, Tissue Engineering, and Other) - Industry Trends and Forecast to 2032

Natural Biomaterial Market

Natural Biomaterial Market Analysis

The natural biomaterial market has experienced substantial growth as demand for sustainable, eco-friendly materials increases in various industries, such as healthcare, food, and packaging. Natural biomaterials, derived from renewable resources such as plants, animals, and microorganisms, offer a wide range of applications, particularly in medical devices, tissue engineering, and regenerative medicine. These materials are biocompatible and biodegradable, making them highly attractive alternatives to synthetic biomaterials, which can be harmful to the environment.

The market is characterized by the rising awareness of sustainability and the need for safer, more efficient materials. Natural biomaterials are gaining traction due to their ability to reduce environmental impact and promote healthier living. In addition, advancements in biotechnology and material science are enabling the development of more refined and functional natural biomaterials that can meet the complex demands of industries such as pharmaceuticals, orthopedics, and wound care.

The market is also witnessing increased investment in research and development to expand the use of natural biomaterials in emerging fields. Companies are exploring innovative approaches to enhance the properties of natural materials, such as improving their mechanical strength and flexibility. As the natural biomaterial market continues to evolve, the shift towards sustainability and innovation is expected to shape the future of material science, providing more environmentally responsible and effective solutions across various sectors.

Natural Biomaterial Market Size

The Natural Biomaterial market size was valued at USD 128.88 billion in 2024 and is projected to reach USD 205.10 billion by 2032, with a CAGR of 5.98% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Natural Biomaterial Market Trends

 “Growing preference for biodegradable and eco-friendly materials across industries.”

The growing preference for biodegradable and eco-friendly materials across industries reflects a broader societal shift towards sustainability and environmental responsibility. As concerns about plastic pollution, waste management, and the depletion of natural resources intensify, companies and consumers alike are seeking alternatives that minimize environmental impact. This shift is particularly noticeable in industries such as packaging, healthcare, and construction, where the adoption of biodegradable materials offers both ecological benefits and practical solutions.

In packaging, for instance, there is a strong move towards biodegradable and compostable materials that replace traditional plastics, which take hundreds of years to decompose. This change is driven by both consumer demand for greener products and increased regulations aimed at reducing plastic waste. Similarly, in the healthcare sector, biodegradable biomaterials are gaining traction for applications such as sutures, wound dressings, and drug delivery systems, where they offer a safer and more sustainable option than synthetic alternatives.

Moreover, industries such as construction and automotive are also exploring eco-friendly materials to reduce their carbon footprints. This growing preference is not only motivated by environmental concerns but also by the potential cost savings associated with using renewable, biodegradable resources. As technology improves and more sustainable materials become available, the trend toward eco-friendly solutions is likely to expand, contributing to a more sustainable and circular economy.

Report Scope Natural Biomaterial Market Segmentation      

Attributes

Natural Biomaterial Key Market Insights

Segments Covered

  • By Type: Hyaluronic Acid, Collagen, Gelatin, Heparin, Fibrin, Cellulose, Chitosan, and Others
  • By Application: Regenerative Medicine, Gene Therapy, Immunotherapy, Stem-Cell Therapy, Cardiovascular, Orthopaedic, Dental, Plastic Surgery, Tissue Engineering, and Other

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Key Market Players

B. Braun SE (Germany), BASF (Germany), Zimmer Biomet (U.S.), Invibio (U.K.), Mimetis Biomaterials (Spain), dsm-firmenich (Netherlands), Medtronic (Ireland), Hollister Incorporated (U.S.), Johnson & Johnson Private Limited (U.S.), Mölnlycke Health Care AB (Sweden), Smith+Nephew (U.K.), Integra LifeSciences Corporation (U.S.), Messe Düsseldorf GmbH (Germany), AnteoTech (Australia), ANYGEN (South Korea), Aphios Corporation (U.S.), ATDBio Ltd (U.K.).

Market Opportunities

  • Growth in Tissue Engineering and Regenerative Medicine
  • Expansion in the Food and Packaging Industries

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Natural Biomaterial Market Definition

Natural biomaterials are materials derived from natural sources, such as plants, animals, or microorganisms, that are used in medical, industrial, or environmental applications. These materials are typically biocompatible, meaning they can interact safely with living tissues, and biodegradable, meaning they break down naturally over time without harming the environment. Natural biomaterials are often used in healthcare for applications such as wound healing, tissue engineering, and implantable devices, due to their ability to integrate well with the body. Instances include collagen, chitosan, alginate, and silk, all of which have properties that make them suitable for medical or other functional uses. In addition, these materials are being explored for their potential to replace synthetic, non-renewable substances in various industries, offering a more sustainable and eco-friendlier alternative.

Natural Biomaterial Market Dynamics

Drivers

  • Increasing Demand for Sustainable Materials

The growing global emphasis on sustainability has significantly driven the natural biomaterial market. Industries are increasingly seeking eco-friendly and biodegradable alternatives to synthetic materials due to the rising concerns about plastic pollution and environmental degradation. Natural biomaterials, derived from renewable resources, offer an effective solution, aligning with the increasing demand for greener products. This shift is particularly evident in sectors such as packaging, healthcare, and construction, where natural biomaterials provide a viable and eco-conscious substitute to harmful materials such as plastics and metals.

  • Advancements in Medical Applications

The healthcare industry is a major driver of the natural biomaterial market. Natural biomaterials, such as collagen, chitosan, and alginate, are being increasingly used in medical applications such as wound care, tissue engineering, and drug delivery systems. These materials possess desirable properties such as biocompatibility, biodegradability, and the ability to promote cell growth and healing, making them ideal for use in the human body. Furthermore, the rise of personalized and regenerative medicine has led to greater demand for natural biomaterials that can be tailored for specific medical needs, fuelling market growth in the healthcare sector.

Opportunities

  • Growth in Tissue Engineering and Regenerative Medicine

The rise of regenerative medicine and tissue engineering presents a significant opportunity for natural biomaterials. These materials play a crucial role in the development of innovative therapies for conditions such as burns, organ failure, and degenerative diseases. Natural biomaterials, such as collagen and hyaluronic acid, are particularly effective for creating scaffolds that support tissue regeneration and repair. As the global population ages and the demand for advanced medical treatments grows, the need for natural biomaterials in these fields is expected to increase significantly, opening up new opportunities for market expansion.

  • Expansion in the Food and Packaging Industries

Natural biomaterials are also finding growing applications in the food and packaging industries, driven by the global trend toward reducing plastic waste. Packaging materials made from biodegradable natural substances, such as starch or cellulose, are becoming increasingly popular as consumers and regulators push for environmentally friendly alternatives to plastic. The use of natural biomaterials in food packaging helps reduce environmental pollution, as these materials decompose more quickly than traditional plastics. With the ongoing shift toward sustainability, the market for natural biomaterials in these industries is set to grow, creating substantial opportunities for manufacturers and innovators.

Restraints/Challenges

  • High Production Costs and Limited Scalability

One significant restraint for the natural biomaterial market is the high production cost associated with extracting and processing natural materials. While natural biomaterials are often considered more sustainable than synthetic alternatives, their production can be labour-intensive and expensive. Moreover, scaling up production to meet the growing demand in industries such as healthcare and packaging can be challenging. The need for specialized processing technologies and raw material sourcing can drive up costs, which may limit their widespread adoption, especially in price-sensitive markets. This barrier is particularly evident when natural biomaterials need to compete with mass-produced synthetic materials.

  • Limited Availability of High-Quality Raw Materials

One of the main challenges faced by the natural biomaterial market is the inconsistent availability of high-quality raw materials. Many natural biomaterials are sourced from biological materials such as plants, animals, and microorganisms, which can be affected by environmental factors such as climate change, agricultural practices, and harvesting conditions. As demand for these materials grows, ensuring a stable, reliable, and sustainable supply of high-quality raw materials becomes increasingly difficult. This challenge could affect production costs and disrupt the supply chain, hindering the growth of the natural biomaterial market

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Natural Biomaterial Market Scope

The market is segmented on the basis of type and application growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Hyaluronic Acid
  • Collagen
  • Gelatin
  • Heparin
  • Fibrin
  • Cellulose
  • Chitosan
  • Others

Application

  • Regenerative Medicine
  • Gene Therapy
  • Immunotherapy
  • Stem-Cell Therapy
  • Cardiovascular
  • Orthopaedic
  • Dental
  • Plastic Surgery
  • Tissue Engineering
  • Other

Natural Biomaterial Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, and application as referenced above.

The countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North American region is the dominating market for natural biomaterials. The region has been at the forefront of innovation and adoption of natural biomaterials, particularly in healthcare applications such as wound care, tissue engineering, and drug delivery systems. The presence of advanced healthcare infrastructure, along with a large number of research and development activities, has propelled the growth of this market. Countries such as the U.S. and Canada have significant investments in the development and commercialization of biocompatible materials. In addition, North America benefits from strong regulatory support and high consumer awareness regarding the benefits of natural biomaterials, driving demand in both the medical and industrial sectors. The presence of major players and continuous technological advancements further solidifies North America’s position as the dominating region in the natural biomaterials market.

Asia Pacific region is the fastest-growing market for natural biomaterials. This region is experiencing rapid growth due to an increasing demand for biodegradable and eco-friendly materials, especially in countries such as China, India, and Japan. The rise in healthcare needs, particularly for wound care, implants, and regenerative medicine, is fuelling the demand for natural biomaterials. In addition, the growing consumer awareness of environmental sustainability is leading to an increased preference for natural alternatives to synthetic materials in industries such as packaging, food, and textiles. The region's expanding healthcare infrastructure, combined with increasing investments in biotechnology, positions Asia Pacific as the fastest-growing region in the natural biomaterials market. Furthermore, the region's large population base and the rise in disposable income contribute to the growing adoption of these materials across various sectors.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Natural Biomaterial Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Natural Biomaterial Market Leaders Operating in the Market Are:

  • B. Braun SE (Germany)
  • BASF (Germany)
  • Zimmer Biomet (U.S.)
  • Invibio (U.K.)
  • Mimetis Biomaterials (Spain)
  • dsm-firmenich (Netherlands)
  • Medtronic (Ireland)
  • Hollister Incorporated (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • Mölnlycke Health Care AB (Sweden)
  • Smith+Nephew (U.K.)
  • Integra LifeSciences Corporation (U.S.)
  • Messe Düsseldorf GmbH (Germany)
  • AnteoTech (Australia)
  • ANYGEN (South Korea)
  • Aphios Corporation (U.S.)
  • ATDBio Ltd (U.K.)

Latest Developments in Natural Biomaterial Market

  • In June 2023, Modern Meadow and BASF announced their collaboration to create a new, innovative animal-free enriched material. This partnership focuses on combining Modern Meadow’s bio-fabrication technology with BASF’s material expertise to produce a sustainable, high-performance material that is free from animal-derived substances. The resulting material aims to offer an eco-friendlier alternative to traditional leather, contributing to a reduction in environmental impact. This innovation is expected to benefit industries such as fashion and automotive by providing a cruelty-free, sustainable material with enhanced durability, performance, and versatility
  • In April 2023, ZimVie announced the recent launch of its RegenerOss™ CC Allograft. This innovative product is designed to aid in bone regeneration and is made from allograft tissue, offering a natural solution for bone repair. The RegenerOss™ CC Allograft provides a bioactive, biocompatible material that promotes the healing process in orthopedic and spine surgeries. This advancement is expected to benefit both patients and healthcare providers by enhancing recovery times and reducing complications associated with traditional synthetic bone graft materials

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The global natural biomaterial market size was valued at USD 128.88 billion in 2024.
The global natural biomaterial market is projected to grow at a CAGR of 5.98% from 2025 to 2032.
The natural biomaterial market is segmented into two notable segments based on type and application. On the basis of type, the market is segmented into hyaluronic acid, collagen, gelatin, heparin, fibrin, cellulose, chitosan and others. On the basis of application, the market is segmented into Regenerative Medicine, Gene Therapy, Immunotherapy, Stem-Cell Therapy, Cardiovascular, Orthopaedic, Dental, Plastic Surgery, Tissue Engineering and Other.
Companies such as B. Braun SE (Germany), BASF (Germany), Zimmer Biomet (U.S.), Invibio (U.K.), Mimetis Biomaterials (Spain), dsm-firmenich (Netherlands) and others are the major companies in the Natural Biomaterial market.
In June 2023, Modern Meadow and BASF announced a collaboration to create an animal-free, sustainable material using bio-fabrication technology, offering an eco-friendly alternative to traditional leather for industries such as fashion and automotive with enhanced durability and performance. In April 2023, ZimVie launched the RegenerOss CC Allograft, a bioactive, biocompatible material made from allograft tissue designed to promote bone regeneration in orthopedic and spine surgeries, offering a natural alternative to synthetic bone grafts and enhancing recovery times.
Testimonial